1528739136764510208

Gamida Cell, the leader in the development of NAM-enabled cell therapies for patients with solid and hematological cancers and other serious diseases, will present at the upcoming H.C. Wainwright Annual Global Investment Conference. Learn more: https://t.co/IzcJ91EJZo https://t.co/96wMpYlYWb

Send us a message